• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[缓控释吗啡在重度癌痛长期治疗中的应用]

[Retard morphine in the long-term therapy of severe tumor pain].

作者信息

Zenz M, Strumpf M, Tryba M, Röhrs E, Steffmann B

机构信息

Universitätsklinik für Anaesthesiologie, Intensiv- und Schmerztherapie, Berufsgenossenschaftliche Krankenanstalten, Bergmannsheil Bochum.

出版信息

Dtsch Med Wochenschr. 1989 Jan 13;114(2):43-7. doi: 10.1055/s-2008-1066549.

DOI:10.1055/s-2008-1066549
PMID:2910700
Abstract

35 patients with severe cancer pain received oral retard morphine. Pain reduction was achieved in each case; duration of effectiveness was between 8 and 12 hours. Mean daily dose was 230 mg morphine, but in individual cases the maximal daily dose had to be over 800 mg. The Karnofsky index of physical capacity was increased in all patients. The main side effect was constipation, which actually increased in the course of treatment. On the other hand, nausea and vomiting decreased after a few weeks. No dependence developed in any of the patients. This form of morphine medication thus was effective over long periods and it has become an important part in the range of strongly effective analgesics.

摘要

35例重度癌痛患者接受了口服缓释吗啡治疗。所有患者的疼痛均得到缓解;有效时长在8至12小时之间。吗啡的平均日剂量为230毫克,但个别病例的最大日剂量不得不超过800毫克。所有患者的卡氏体能指数均有所提高。主要副作用是便秘,实际上在治疗过程中便秘情况还加重了。另一方面,几周后恶心和呕吐症状减轻。所有患者均未产生依赖性。因此,这种吗啡给药方式长期有效,已成为强效镇痛药中的重要组成部分。

相似文献

1
[Retard morphine in the long-term therapy of severe tumor pain].[缓控释吗啡在重度癌痛长期治疗中的应用]
Dtsch Med Wochenschr. 1989 Jan 13;114(2):43-7. doi: 10.1055/s-2008-1066549.
2
[Long-term therapy of tumor pain using morphine-retard tablets].[使用缓释吗啡片对肿瘤疼痛进行长期治疗]
Med Klin (Munich). 1990 Sep 15;85(9):523-8.
3
[Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].[盐酸吗啡缓释片治疗癌痛的效果:567例患者的调查]
Zhonghua Yi Xue Za Zhi. 2004 Mar 17;84(6):450-5.
4
[Treatment of chronic pain in advanced malignant disease by oral morphine (author's transl)].
Nouv Presse Med. 1979 Oct 15;8(39):3119-21.
5
[Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].[使用成人镇痛药治疗儿童癌症疼痛的可行性及其疗效]
Ai Zheng. 2007 Aug;26(8):866-9.
6
[Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].[用于慢性非肿瘤性疼痛的吗啡片。哪些因素会影响长期治疗的成败?]
Anaesthesist. 1993 Aug;42(8):545-56.
7
Evaluation of tolerance in long-term treatment of cancer pain with epidural morphine.硬膜外吗啡长期治疗癌痛的耐受性评估。
Int J Clin Pharmacol Ther Toxicol. 1983 Nov;21(11):587-90.
8
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.缓释口服吗啡与透皮芬太尼及口服美沙酮在癌症疼痛管理中的比较
Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18.
9
A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.一项随机、双盲、安慰剂对照、交叉试点研究,旨在评估长期服用阿片类药物及随后戒断对接受缓释吗啡治疗的慢性非癌性疼痛患者的影响。
Pain Med. 2005 Mar-Apr;6(2):113-21. doi: 10.1111/j.1526-4637.2005.05020.x.
10
Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.两例癌症疼痛患者中,低剂量氯胺酮加入吗啡-布比卡因混合物硬膜外给药的有益效果。
Pain Med. 2006 Mar-Apr;7(2):166-9. doi: 10.1111/j.1526-4637.2006.00111.x.

引用本文的文献

1
[Slow-release morphine liquid suspension for the therapy of cancer pain and non-cancer pain-A pilot study.].
Schmerz. 1995 May;9(3):140-6. doi: 10.1007/BF02530132.
2
[Not Available].[无可用内容]
Schmerz. 1995 Nov;9(6):317-8. doi: 10.1007/BF02530162.
3
[Prescription of strong opioids by physicians.].[医生开具强效阿片类药物的处方。]
Schmerz. 1990 Sep;4(3):151-6. doi: 10.1007/BF02527878.
4
[Intractable cancer pain as a reason for referral : Analysis of pain etiology and previous drug treatment.].[以顽固性癌痛作为转诊原因:疼痛病因及既往药物治疗分析。]
Schmerz. 1990 Dec;4(4):193-200. doi: 10.1007/BF02527903.
5
[The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.].[不同阿片类药物或不同给药途径用于癌症疼痛治疗时肌内注射吗啡等效剂量的估算。实际意义及局限性。]
Schmerz. 1990 Jun;4(2):110-7. doi: 10.1007/BF02527845.
6
[Pain relief in the final stage of cancer.].[癌症终末期的疼痛缓解。]
Schmerz. 1990 Mar;4(1):22-8. doi: 10.1007/BF02527826.
7
[Oral opioids in patients with non-malignant pain.].[非恶性疼痛患者使用口服阿片类药物。]
Schmerz. 1990 Mar;4(1):14-21. doi: 10.1007/BF02527825.
8
[Opioids in "non-malignant" pain-results of long-term treatment in patients with rheumatic disease.].
Schmerz. 1991 Jun;5(2):60-6. doi: 10.1007/BF02529469.
9
[Not Available].
Schmerz. 1991 Mar;5(Supplement 1):S52-63. doi: 10.1007/BF02530070.
10
Comparison of Two Oral Morphine Formulations for Chronic Severe Pain of Malignant and Nonmalignant Origin: Kapanol(trade mark) vs MST((R)).两种口服吗啡制剂用于治疗恶性和非恶性来源的慢性重度疼痛的比较:卡巴酚(商标名)与美施康定(商标名)对比
Clin Drug Investig. 1998;15(1):69-71. doi: 10.2165/00044011-199815010-00011.